Fig. 2
Effect of IVF-ET on glucose and lipid metabolism of male offspring. A: Glucose tolerance test in 4-week-old chow-fed male offspring (nNC−chow=11, nIVF−chow=12). B: Fast glucose of chow and HFD treatment male offspring at 4,10,16 weeks (nNC−chow=13, nIVF−chow=12, nNC−HFD=13, nNC−HFD=13). C: Fast insulin of chow and HFD treatment male offspring at 4,10,16 weeks (nNC−chow=10, nIVF−chow=11, nNC−HFD=11, nNC−HFD=11). D: HOMA-IR of chow and HFD treatment male offspring at 4,10,16 weeks (nNC−chow=10, nIVF−chow=11, nNC−HFD=11, nNC−HFD=11). E: Lipid profile of chow and HFD treatment male offspring at 10,16 weeks (Left:TC, nNC−chow=11, nIVF−chow=11, nNC−HFD=12, nNC−HFD=12; Middle:TG, nNC−chow=12, nIVF−chow=11, nNC−HFD=12, nNC−HFD=11; Right:LDL, nNC−chow=11, nIVF−chow=12, nNC−HFD=12, nNC−HFD=11). *Indicates a significant difference (P < 0.05) between NC-Chow and IVF-Chow; #denotes NC-HFD vs. IVF-HFD (P < 0.05); ‘ns’ indicates a increased tend in IVF-Chow (0.05 < P < 0.1)